Furthermore, gastric tumors with MSI-high status and/or AT-rich interaction domain 1A (ARID1A) loss, molecular subtypes enriched in certain gastric cancer subsets, exhibit impaired HR and defective G2/M checkpoint control. This evidence concerns the gene ARID1A and gastric cancer.